Raw Farm E. Coli Outbreak Ends; Congress Questions Why FDA Never Used Mandatory Recall Authority

Why It Matters

The episode highlights a gap in FDA’s enforcement toolkit, raising concerns about public‑health protection when companies resist voluntary recalls. Congressional scrutiny could prompt regulatory reforms that strengthen mandatory recall use and restore consumer confidence in food safety oversight.

Key Takeaways

• Outbreak caused nine illnesses, three hospitalizations, one HUS case
• FDA found one positive cheese sample, linked to a different 2025 outbreak
• Raw Farm initially refused voluntary recall, later complied under protest
• Congressional hearing questioned why FDA did not invoke mandatory recall power

Pulse Analysis

The Raw Farm E. coli outbreak, which began in September 2025 and concluded in February 2026, resulted in nine confirmed illnesses across California, Nevada and Arizona. FDA’s investigation uncovered a single contaminated cheddar cheese sample, but whole‑genome sequencing tied it to a prior 2025 outbreak, leaving the current cases without a direct product link. Despite epidemiologic evidence implicating Raw Farm’s raw dairy, the company resisted a voluntary recall for weeks, ultimately withdrawing the cheese under protest. This standoff underscores the challenges regulators face when voluntary compliance falters.

FDA’s mandatory recall authority, codified under the Food Safety Modernization Act, has been exercised only twice since its inception. The agency typically relies on voluntary recalls, assuming industry cooperation to protect public health. In the Raw Farm case, the reluctance to invoke compulsory power sparked criticism from the Association of Food and Drug Officials and raised questions about consistency in enforcement. Experts argue that rare use of mandatory recalls may embolden non‑compliant firms, while others caution that over‑use could strain industry relationships and create legal pushback.

The controversy quickly moved to Capitol Hill, where a House Subcommittee on Health interrogated the FDA’s decision‑making and probed potential political influence from Health Secretary Robert F. Kennedy Jr. Lawmakers fear that perceived leniency could erode consumer trust in the food supply chain. Calls for clearer guidelines on when mandatory recalls are warranted are gaining momentum, and future legislation may tighten the criteria for agency action. For stakeholders—from dairy producers to public‑health advocates—the episode serves as a reminder that robust, transparent recall mechanisms are essential to safeguarding the market and preventing avoidable illness outbreaks.